Longevity & Biohacking · Dr. Sophie Lane · 5 November 2026

Why male mice lose anti-cancer immunity earlier than females

Why male mice lose anti-cancer immunity earlier than females

Researchers found why male mice lose anti-cancer immunity earlier than females: androgens accelerate thymic involution and push naive CD8+ T cells into virtual memory states that proliferate poorly, depleting the antigen-recognition reserve needed to fight new tumors by middle age. A Massachusetts General Hospital team published the findings in Nature Aging, and restoring thymic activity improved male protection.

Key Takeaways

What did the mouse cancer experiments show?

When researchers implanted melanoma into young and middle-aged mice, tumor growth looked similar in young males and females. By middle age, males controlled tumors less effectively than females.

Depleting CD8+ T cells sped tumor growth in both sexes and erased the female advantage, tying the gap to this killer T cell type. Middle-aged females had more tumor-specific, activated CD8+ cells inside tumors. You can follow related longevity immune research in our Longevity & Biohacking hub.

Why do male mice lose naive T cell reserves sooner?

Lymph nodes—not the spleen—drove the stronger female response. Female tumor-draining nodes held more activated, tumor-specific CD8+ cells without faster proliferation or better antigen presentation. The bottleneck was supply: absolute naive CD8+ counts fell with age, and male mice started losing them earlier.

Males also skewed earlier toward “virtual memory” cells—naive T cells that adopt a memory-like state without matching antigen. Those cells released more cytokines after stimulation but expanded less well and showed more senescence-linked gene expression. Brief IL-15 treatment that boosted virtual memory in young females later left them with fewer naive CD8+ cells and weaker tumor control.

Can restoring the thymus close the sex gap?

The thymus, where T cells mature, involutes faster in males. After immune depletion, middle-aged females rebuilt naive CD8+ pools faster and showed more recent thymic emigrants. Removing the thymus at six weeks wiped out the female advantage in middle-age melanoma control.

Because androgens suppress thymic activity, researchers cut androgen signaling via castration or degarelix. That increased thymic cellularity, repopulated lymph nodes, restored naive CD8+ numbers, and improved melanoma control in middle-aged males, substantially shrinking the sex difference. Coverage of the study is available from Lifespan.io, which summarized the Nature Aging paper amid a busy month of rejuvenation research noted in its October 2026 Rejuvenation Roundup.

The work does not prove clinical therapies for men. It does map a hormone–thymus–naive T cell pathway that may help explain why some cancer rates diverge by sex around midlife.

← Open in blast feed